These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 27999163)

  • 41. Phase 1 evaluation of Vibrio cholerae O1, serotype Inaba, polysaccharide-cholera toxin conjugates in adult volunteers.
    Gupta RK; Taylor DN; Bryla DA; Robbins JB; Szu SC
    Infect Immun; 1998 Jul; 66(7):3095-9. PubMed ID: 9632571
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Variable gene family usage of protective and non-protective anti-Vibrio cholerae O1 LPS antibody heavy chains.
    Wade TK; Wade WF
    Microbiol Immunol; 2008 Dec; 52(12):611-20. PubMed ID: 19120975
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cholera toxin modulates the systemic immune responses against Vibrio cholerae surface antigens after repeated inoculations.
    Fernandez-Miyakawa ME; Brero ML; Mateo NA
    Microbiol Immunol; 2006; 50(8):607-19. PubMed ID: 16924145
    [TBL] [Abstract][Full Text] [Related]  

  • 44. B-cell responses to lipopolysaccharide epitopes: Who sees what first - does it matter?
    Wade WF
    Am J Reprod Immunol; 2006; 56(5-6):329-36. PubMed ID: 17076677
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antigen-specific memory B-cell responses in Bangladeshi adults after one- or two-dose oral killed cholera vaccination and comparison with responses in patients with naturally acquired cholera.
    Alam MM; Riyadh MA; Fatema K; Rahman MA; Akhtar N; Ahmed T; Chowdhury MI; Chowdhury F; Calderwood SB; Harris JB; Ryan ET; Qadri F
    Clin Vaccine Immunol; 2011 May; 18(5):844-50. PubMed ID: 21346055
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of immune responses in patients infected with Vibrio cholerae O139 and O1.
    Qadri F; Wennerås C; Albert MJ; Hossain J; Mannoor K; Begum YA; Mohi G; Salam MA; Sack RB; Svennerholm AM
    Infect Immun; 1997 Sep; 65(9):3571-6. PubMed ID: 9284121
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cholera toxin-specific memory B cell responses are induced in patients with dehydrating diarrhea caused by Vibrio cholerae O1.
    Jayasekera CR; Harris JB; Bhuiyan S; Chowdhury F; Khan AI; Faruque AS; Larocque RC; Ryan ET; Ahmed R; Qadri F; Calderwood SB
    J Infect Dis; 2008 Oct; 198(7):1055-61. PubMed ID: 18729782
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A monoclonal antibody that targets the conserved core/lipid A region of lipopolysaccharide affects motility and reduces intestinal colonization of both classical and El Tor Vibrio cholerae biotypes.
    Levinson KJ; Baranova DE; Mantis NJ
    Vaccine; 2016 Nov; 34(48):5833-5836. PubMed ID: 27773473
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis, characterization, and some immunological properties of conjugates composed of the detoxified lipopolysaccharide of Vibrio cholerae O1 serotype Inaba bound to cholera toxin.
    Gupta RK; Szu SC; Finkelstein RA; Robbins JB
    Infect Immun; 1992 Aug; 60(8):3201-8. PubMed ID: 1639490
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The binding of synthetic analogs of the upstream, terminal residue of the O-polysaccharides (O-PS) of Vibrio cholerae O:1 serotypes Ogawa and Inaba to two murine monoclonal antibodies (MAbs) specific for the Ogawa lipopolysaccharide (LPS).
    Liao X; Poirot E; Chang AH; Zhang X; Zhang J; Nato F; Fournier JM; Kovác P; Glaudemans CP
    Carbohydr Res; 2002 Nov; 337(24):2437-42. PubMed ID: 12493228
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunological cross-reactivity between a heat-labile enterotoxin(s) of Escherichia coli and subunits of Vibrio cholerae enterotoxin.
    Clements JD; Finkelstein RA
    Infect Immun; 1978 Sep; 21(3):1036-9. PubMed ID: 361573
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human monoclonal antibodies isolated from a primary pneumococcal conjugate Vaccinee demonstrates the expansion of an antigen-driven Hypermutated memory B cell response.
    Chen Z; Cox KS; Tang A; Roman J; Fink M; Kaufhold RM; Guan L; Xie A; Boddicker MA; Mcguinness D; Xiao X; Li H; Skinner JM; Verch T; Retzlaff M; Vora KA
    BMC Infect Dis; 2018 Dec; 18(1):613. PubMed ID: 30509199
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Infection and immunity to Vibrio cholerae, Salmonella typhimurium and Escherichia coli in a rabbit model.
    Guinée PA; Jansen WH; Rijpkema SG
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Nov; 270(1-2):260-9. PubMed ID: 2464884
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of memory B cell, antibody-secreting cell, and plasma antibody responses in young children, older children, and adults with infection caused by Vibrio cholerae O1 El Tor Ogawa in Bangladesh.
    Leung DT; Rahman MA; Mohasin M; Riyadh MA; Patel SM; Alam MM; Chowdhury F; Khan AI; Kalivoda EJ; Aktar A; Bhuiyan MS; LaRocque RC; Harris JB; Calderwood SB; Qadri F; Ryan ET
    Clin Vaccine Immunol; 2011 Aug; 18(8):1317-25. PubMed ID: 21697337
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Local production of anti-vibrio cholerae mucosal antibody in reproductive tract tissues after cholera.
    Ryan ET; Bridges EA; Crean TI; Gausia K; Hamadani JD; Aziz A; Hawkes S; Begum M; Bogaerts J; Faruque SM; Salam MA; Fuchs GJ; Calderwood SB
    J Infect Dis; 2001 Sep; 184(5):643-7. PubMed ID: 11494170
    [TBL] [Abstract][Full Text] [Related]  

  • 56. On the antigenic determinants of the lipopolysaccharides of Vibrio cholerae O:1, serotypes Ogawa and Inaba.
    Wang J; Villeneuve S; Zhang J; Lei P; Miller CE; Lafaye P; Nato F; Szu SC; Karpas A; Bystricky S; Robbins JB; Kovác P; Fournier JM; Glaudemans CP
    J Biol Chem; 1998 Jan; 273(5):2777-83. PubMed ID: 9446585
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antigen-specific immunoglobulin A antibodies secreted from circulating B cells are an effective marker for recent local immune responses in patients with cholera: comparison to antibody-secreting cell responses and other immunological markers.
    Qadri F; Ryan ET; Faruque AS; Ahmed F; Khan AI; Islam MM; Akramuzzaman SM; Sack DA; Calderwood SB
    Infect Immun; 2003 Aug; 71(8):4808-14. PubMed ID: 12874365
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Monoclonal antibodies to cholera toxin with special reference to cross-reactions with Escherichia coli heat-labile enterotoxin.
    Lindholm L; Holmgren J; Wikström M; Karlsson U; Andersson K; Lycke N
    Infect Immun; 1983 May; 40(2):570-6. PubMed ID: 6840852
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Detection of Vibrio cholerae with monoclonal antibodies specific for serovar O1 lipopolysaccharide.
    Adams LB; Henk MC; Siebeling RJ
    J Clin Microbiol; 1988 Sep; 26(9):1801-9. PubMed ID: 3053778
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of ADP-ribosylation and G(M1)-binding activity in the mucosal immunogenicity and adjuvanticity of the Escherichia coli heat-labile enterotoxin and Vibrio cholerae cholera toxin.
    de Haan L; Verweij W; Agsteribbe E; Wilschut J
    Immunol Cell Biol; 1998 Jun; 76(3):270-9. PubMed ID: 9682971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.